Rietermann to Lead Siemens Healthcare in U.S.

Siemens Healthcare has named Michael Reitermann CEO of its U.S. operations.

Reitermann succeeds Dr. Heinrich Kolem, who will become the global head of Siemens Healthcare’s Angiography, Fluoroscopy and X-ray business unit, which is based in Forchheim, Germany.

Reitermann will lead the marketing, sales and service functions for Siemens Healthcare in the United States and will be based at the unit’s U.S. headquarters in Malvern, Pa. Businesses that fall under his purview include medical imaging, therapy and health-care information technology.

Reitermann had been CEO of Siemens Molecular Imaging since Siemens formed it in 2005 after acquiring CTI Molecular Imaging Inc. He had been the president of its predecessor unit at Siemens, Siemens Nuclear Medicine, since 2002.

Last year, Siemens Medical Solutions, a division of the German engineering giant announced that it would invest $60 million to expand its Wake County operations and create a training and services headquarters at its Cary campus.

SMS anticipated it would add another 300 jobs in Cary, where it already employed 678. The average pay for the new jobs is projected to be $73,000 a year.

The company would qualify for more than $5.6 million in economic incentives through the state’s Job Development Investment Grant program if it creates the jobs promised under the agreement and sustains them for 10 years. The town of Cary also approved a $500,000 grant to Siemens to secure the project.

Siemens Healthcare employs 49,000 people and operates in 130 countries. It is a unit of Siemens AG, a conglomerate based in Munich, Germany.